MK, VSFATIN, GAS, and TWEAK signaling pathways occupied a dominant position in the PAH group, while ANGPTL, CALCR, GDF, and CSF3 signaling pathways were specifically enriched in the control group (Fig. 3C). This evidence concerns the gene TNFSF12 and pulmonary arterial hypertension.